What We're Reading: Page 331
Industry reads hand-picked by our editors
Jun 29, 2016
-
Reuters
FDA names Pazdur head of new Oncology Center of Excellence
-
Bloomberg
Allergan Seeks Smaller M&A for Growth After Pfizer Breakup
-
The Street
Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill
-
PM Live
inVentiv Health wins Pfizer account
-
HR Dive
Creating a 'culture of data': How HR can use analytics in a meaningful way
Jun 28, 2016
-
Boston Business Journal
Why Sarepta just made its soon-to-begin drug trial even longer
-
Stat
The Supreme Court decision that’s shaking up biotech
-
Xconomy
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week
-
The Pharma Letter
Roche’s Ocrevus for two forms of MS accepted for review by EMA and FDA
Jun 27, 2016
-
Bloomberg
‘Sea Turtles’ Give China’s Drug Startups a Shot in the Arm
-
Wall Street Journal
Biotech Labs Birth New Drugs—and New Fortunes
-
San Diego Magazine
What's It Like to Be the CEO of the Smartest Company in the World?
-
Reuters
Allergy Therapeutics says study fails to find hay fever therapy dose range
Previous
